Special Issue "Sphingolipids in Cancer Progression and Therapy"
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (15 November 2020).
Interests: sphingolipids; ceramides; sphingotherapy; cancer therapy; cancer biology; cancer metastasis; cellular signaling; cell death; necroptosis
Special Issues and Collections in MDPI journals
This Special Issue highlights the role of sphingolipids in cancer progression and therapy. Cancer progression is closely associated with cell death, growth, differentiation, angiogenesis, cell motility, metastasis, and inflammatory responses. In recent years, it has become apparent that sphingolipids such as ceramide, sphingosine, and sphingosine-1-phosphate are involved in cancer progression. Especially, ceramide signaling has been implicated in programmed necrosis (necroptosis), whose study may advance the understanding of cancer cell death and ceramide-based cancer therapy. Uncovering the mechanisms by which different sphingolipids regulate cancer pathobiology may promote the development of novel therapies against cancer.
We invite investigators to contribute original research articles as well as review articles that will stimulate continuing efforts to understand the pathobiology of sphingolipids in cancer and provide valuable mechanistic insights that may translate to therapeutic opportunities. This Special Issue will accept basic research, bioinformatic research, translational research, and (pre) clinical research papers.
Dr. Kazuyuki Kitatani
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.